抗Human SOST Biotinylated抗体(Anti-Human SOST Biotinylated antibody)
掲載日情報:2021/01/28 現在Webページ番号:195202
Human SOST Biotinylatedに対する抗体(Anti-Human SOST Biotinylated )です。
※ 本製品は研究用です。研究用以外には使用できません。
カートに商品を
追加しました。
追加しました。
- 価格
- Product Details
- Applications and Data
- References
- Related Research Areas
- Related Product & Information
価格
[在庫・価格 :2025年04月27日 00時00分現在]
※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 | 商品名 |
|
文献数 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-Human SOST Biotinylated MAb (Clone 220910) |
|
0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
[在庫・価格 :2025年04月27日 00時00分現在]
※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
Anti-Human SOST Biotinylated MAb (Clone 220910)
文献数: 0
- 商品コード:BAM14061
- メーカー:RSD
- 包装:250μg
- 価格:¥118,000
- 在庫:無(未発注)
- 納期:10日程度 ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。
- 法規制等:
説明文 | マッチドペア:Human SOST サンドイッチELISAの検出用抗体として利用可能,補足用抗体として#MAB1406-500,スタンダードとして#1406-ST-025を用いる。 別名:sclerostin クローン:220910 Genbank No: 50964 Protein Accession No: Q9BQB4 |
||
---|---|---|---|
法規制等 | |||
保存条件 | -20℃ | 法規備考 | |
抗原種 | 免疫動物 | Mouse | |
交差性 | Human | 適用 | ELISA |
標識 | Biotin | 性状 | Protein A/G Affinity Purified |
吸収処理 | クラス | IgG | |
クロナリティ | Monoclonal | フォーマット | |
掲載カタログ |
|
||
製品記事 | Quantikine SOST ELISA Kit |
||
関連記事 | R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド |
カートに商品を
追加しました。
追加しました。
Product Details
Species Reactivity | Human |
---|---|
Label | Biotin |
Immunogen | Mouse myeloma cell line NS0-derived recombinant human SOST/SclerostinGln24-Tyr213Accession # Q9BQB4 |
Source | Monoclonal Mouse IgG1 Clone # 220910 |
Purification | Protein A or G purified from hybridoma culture supernatant |
Specificity | Detects human SOST/Sclerostin in ELISAs. In sandwich immunoassays, 30% cross-reactivity with recombinant mouse SOST is observed and no cross-reactivity or interference with recombinant human BMP-2, -4, -5, -6, or -7 was observed. |
カートに商品を
追加しました。
追加しました。
Applications and Data
Recommended Concentration | Sample | |
Human SOST Sandwich Immunoassay | Reagent | |
ELISA Capture (Matched Antibody Pair) | 2-8 µg/mL | Human SOST/Sclerostin Antibody (Catalog #MAB1406 ) |
ELISA Detection (Matched Antibody Pair) | 0.5-2.0 µg/mL | Human SOST/Sclerostin Biotinylated Antibody (Catalog #BAM14061 ) |
ELISA Standard | Recombinant Human SOST/Sclerostin Protein (Catalog #1406-ST ) | |
Please Note: Optimal dilutions should be determined by each laboratory for each application.General Protocolsare available in the Technical Information section on our website. | Preparation and Storage | |
Reconstitution | Reconstitute at 0.5 mg/mL in sterile PBS. | Reconstitution Buffer Available |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. | |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. | |
1 month, 2 to 8 °C under sterile conditions after reconstitution. | ||
6 months, -20 to -70 °C under sterile conditions after reconstitution. | ||
Background: SOST/Sclerostin | SOST, also known as sclerostin, is a member of the cerberus/DAN family, a group of secreted glycoproteins characterized by a cysteine-knot motif. Cerberus/DAN family members are putative BMP antagonists, and include Dan, Cerberus, Gremlin, PRDC, and Caronte. While the overall sequence identity between members of the family is low, they have conserved spacing of six cysteine residues. Cerberus and dan have an additional cysteine residue used for dimerization; however, SOST does not and is secreted as a monomer. SOST was originally identified as an important regulator of bone homesotasis. Positional cloning studies identified that mutations in the SOST gene can cause sclerosteosis and van Buchem disease, bone dysplasia disorders characterized by progressive skeletal overgrowth. Significant levels of SOST expression are detected in bone, cartilage, kidney, and liver. SOST is expressed by osteoclasts in developing bones of mouse embryos, including both intramembranously forming skull bones and endochondrally forming long bones. SOST plays a physiological role as a negative regulator of bone formation by repressing BMP-induced osteogenesis. SOST has been shown to have unique ligand specificity, binding BMP-5, -6, and -7 with high affinity and BMP-2 and -4 with low affinity. This seems to be the first example of a BMP antagonist being localized to osteoclasts, cells derived from the hematopoietic lineage, that function to degrade bone matrix. Recombinant human SOST preparations from R&D Systems bind BMP-5 and BMP-6 in a functional ELISA. Human and mouse SOST share 88% amino acid identity (1‑3). |
カートに商品を
追加しました。
追加しました。
References
Kusu, N. et al. (2003) J. Biol. Chem. 278:24113. | |
Balemans, W. et al. (2001) Hum. Mol. Genet. 10:537. | |
Brunkow, M.E. et al. (2001) Am. J. Hum. Genet. 68:577. | |
Entrez Gene IDs: | 50964 (Human); 74499 (Mouse) |
Alternate Names: | sclerostin; SOST; VBCHsclerosteosis |
カートに商品を
追加しました。
追加しました。
Related Research Areas
BMP Family |
Osteocyte Markers |
Osteogenesis Markers |
TGF-beta Superfamily Modulators |
Wnt Inhibitors |
カートに商品を
追加しました。
追加しました。
Related Product & Information
Background | SOST/Sclerostin |
---|---|
background_content | Background: SOST/Sclerostin SOST, also known as sclerostin, is a member of the cerberus/DAN family, a group of secreted glycoproteins characterized by a cysteine-knot motif. Cerberus/DAN family members are putative BMP antagonists, and include Dan, Cerberus, Gremlin, PRDC, and Caronte. While the overall sequence identity between members of the family is low, they have conserved spacing of six cysteine residues. Cerberus and dan have an additional cysteine residue used for dimerization; however, SOST does not and is secreted as a monomer. SOST was originally identified as an important regulator of bone homesotasis. Positional cloning studies identified that mutations in the SOST gene can cause sclerosteosis and van Buchem disease, bone dysplasia disorders characterized by progressive skeletal overgrowth. Significant levels of SOST expression are detected in bone, cartilage, kidney, and liver. SOST is expressed by osteoclasts in developing bones of mouse embryos, including both intramembranously forming skull bones and endochondrally forming long bones. SOST plays a physiological role as a negative regulator of bone formation by repressing BMP-induced osteogenesis. SOST has been shown to have unique ligand specificity, binding BMP-5, -6, and -7 with high affinity and BMP-2 and -4 with low affinity. This seems to be the first example of a BMP antagonist being localized to osteoclasts, cells derived from the hematopoietic lineage, that function to degrade bone matrix. Recombinant human SOST preparations from R&D Systems bind BMP-5 and BMP-6 in a functional ELISA. Human and mouse SOST share 88% amino acid identity (1‑3). |
カートに商品を
追加しました。
追加しました。
製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。